AstraZeneca PLC (AZN) — Capital Reinvestment Ratio
Latest as of March 2026:
0.46x
AstraZeneca PLC (AZN) has a Capital Reinvestment Ratio of 0.46x as of March 2026, meaning it reinvests 0% of its operating cash flow ($3.36 Billion) in capital expenditures ($1.54 Billion). See cash generation quality of AstraZeneca PLC to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.46x
Capex / Operating Cash Flow
Operating Cash Flow
$3.36 Billion
USD
Capital Expenditures
$1.54 Billion
USD
Data as of
Mar 2026
Most recent filing
AstraZeneca PLC Capital Reinvestment Ratio (1990–2025)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 36 annual periods.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (1990–2025)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 1990 to 2025. For live market cap and broader valuation context, see market value of AstraZeneca PLC.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $14.57 Billion | $2.81 Billion | ▼ -50.1% |
| 2024 | 0.39x | $11.86 Billion | $4.59 Billion | ▲ +5.9% |
| 2023 | 0.37x | $10.35 Billion | $3.78 Billion | ▲ +39.3% |
| 2022 | 0.26x | $9.81 Billion | $2.57 Billion | ▼ -29.0% |
| 2021 | 0.37x | $5.96 Billion | $2.20 Billion | ▼ -32.1% |
| 2020 | 0.54x | $4.80 Billion | $2.61 Billion | ▼ -34.5% |
| 2019 | 0.83x | $2.97 Billion | $2.46 Billion | ▲ +58.2% |
| 2018 | 0.52x | $2.62 Billion | $1.37 Billion | ▲ +15.7% |
| 2017 | 0.45x | $3.58 Billion | $1.62 Billion | ▼ -18.9% |
| 2016 | 0.56x | $4.14 Billion | $2.31 Billion | ▼ -33.4% |
| 2015 | 0.84x | $3.32 Billion | $2.79 Billion | ▲ +115.1% |
| 2014 | 0.39x | $7.06 Billion | $2.75 Billion | ▲ +40.2% |
| 2013 | 0.28x | $7.40 Billion | $2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | $6.95 Billion | $4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | $7.82 Billion | $1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | $10.68 Billion | $2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | $11.74 Billion | $2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | $8.74 Billion | $4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | $7.51 Billion | $1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | $7.69 Billion | $1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | $6.74 Billion | $979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | $4.87 Billion | $332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | $3.42 Billion | $1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | $4.83 Billion | $1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | $2.71 Billion | $2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | $2.34 Billion | $1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | $908.55 Million | $2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | $879.74 Million | $844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | $747.21 Million | $755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | $787.75 Million | $638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | $585.64 Million | $431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | $625.36 Million | $492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | $705.58 Million | $462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | $206.27 Million | $406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | $505.22 Million | $385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | $806.30 Million | $540.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow